Clinical Trial Update: Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing rosiglitazone monotherapy to metformin or glyburide for type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glyburide (glyburide)
• Rosiglitazone (rosiglitazone)
• metformin (metformin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED